• Emergent BioSolutions Awarded $62.4 Million Contract Modification for BAT® Antitoxin by U.S. Department of Health and Human Services

    المصدر: NASDAQ Stocks / 23 يونيو 2025 06:24:15   America/Los_Angeles

    Emergent BioSolutions receives a $62.4 million contract modification to supply Botulism Antitoxin for U.S. public health protection. https://www.nasdaq.com/articles/emergent-biosolutions-awarded-624-million-contract-modification-batr-antitoxin-us
شارك على،